Sampo plc
23.9.2026 15:40:00 CEST | Globenewswire | Press release
Announcement of Sampo plc’s results and Annual General Meeting in 2027
Announcement of Sampo plc’s results and Annual General Meeting in 2027
Sampo plc, stock exchange release, 23 September 2026 at 4:40 pm EEST
Announcement of Sampo plc’s results and Annual General Meeting in 2027
Sampo plc will publish a Financial Statement Release for 2026 on 4 February 2027. Sampo will report its results on following days during 2027:
- 5 May 2027: Interim Statement for the period January–March 2027
- 11 August 2027: Half-Year Financial Report for the period January–June 2027
- 3 November 2027: Interim Statement for the period January–September 2027
The financial results will be published at approximately 8:30 am Finnish time (6:30 am UK time).
The Financial Statements and the Board of Directors’ Report, including Corporate Governance Statement and Sustainability Statement, and the Remuneration Report for Governing Bodies for 2026 will be published at www.sampo.com/year2026 during week 12.
The Annual General Meeting of Sampo plc is planned to be held on Wednesday, 21 April 2027. A shareholder may request that a matter falling under the authority of the General Meeting of Shareholders shall be placed on the agenda of the AGM. To this effect, a written request should be sent to the Board of Directors on Wednesday, 17 February 2027, at the latest.
Sampo Group’s Solvency and Financial Condition Report (SFCR) will be published in May 2027.
SAMPO PLC
Investor Relations and Group Communications
For further information, please contact:
Mirko Hurmerinta
Interim Head of Investor Relations
tel. +358 10 516 0032
Distribution:
Nasdaq Helsinki
Nasdaq Stockholm
Nasdaq Copenhagen
London Stock Exchange
FIN-FSA
The principal media
www.sampo.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novartis Pharma AG13.11.2026 19:30:00 CET | Press release
Novartis receives positive CHMP opinion for Cosentyx® in adolescents aged 12+ with hidradenitis suppurativa (HS)
Shufti Pro Limited13.11.2026 19:00:00 CET | Press release
Shufti Launches Patented On-Device AI Age Verification, Taking User Privacy Concerns Out of the Equation
XPENG13.11.2026 18:10:49 CET | Press release
XPENG Announces UK Pricing for New L03 and Flagship G9L, Starting from £32,990 and £64,990
Wolters Kluwer N.V.13.11.2026 18:00:00 CET | Press release
Wolters Kluwer to acquire AI-powered clinical decision support platform AgileMD
Novo Nordisk A/S13.11.2026 17:46:41 CET | Press release
FREHEMGO® (denecimig) approved in the EU for haemophilia A, with a choice of monthly, every-two-weeks or weekly dosing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom